UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Online Fundraisers: Targeted Planning and Successful Implementation

1, 2022

Volltextzugriff (PDF)

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

Canadian Medical Association journal (CMAJ), 2010-11, Vol.182 (17), p.1864-1873

2010

Volltextzugriff (PDF)

Risk factors for low bone mass in healthy 40-60 year old women: A systematic review of the literature

Osteoporosis international, 2009-01, Vol.20 (1), p.1-21

2009

Volltextzugriff (PDF)

Trabecular bone score in kidney transplant recipients

Osteoporosis international, 2016-03, Vol.27 (3), p.1115-1121

2016

Volltextzugriff (PDF)

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

The New England journal of medicine, 2001-05, Vol.344 (19), p.1434-1441

2001

Volltextzugriff (PDF)

Rates and Properties of Type Ia Supernovae as a Function of Mass and Star Formation in Their Host Galaxies

The Astrophysical journal, 2006-09, Vol.648 (2), p.868-883

2006

Volltextzugriff (PDF)

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

The journal of clinical endocrinology and metabolism, 2000-06, Vol.85 (6), p.2129-2134

2000

Volltextzugriff (PDF)

Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures

Osteoporosis international, 2005-04, Vol.16 (4), p.403-410

2005

Volltextzugriff (PDF)

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis

Bone (New York, N.Y.), 2000-08, Vol.27 (2), p.311-318

2000

Volltextzugriff (PDF)

Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

Endocrine reviews, 2005-08, Vol.26 (5), p.688-703

2005

Volltextzugriff (PDF)

Long‐term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial

Journal of thrombosis and haemostasis, 2007-08, Vol.5 (8), p.1600-1606

2007

Volltextzugriff (PDF)

Nuclear Localization of the Type 1 PTH/PTHrP Receptor in Rat Tissues

Journal of bone and mineral research, 2000-06, Vol.15 (6), p.1033-1044

2000

Volltextzugriff (PDF)

Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis

Canadian Medical Association journal (CMAJ), 2006-07, Vol.175 (1), p.48-48

2006

Volltextzugriff (PDF)

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone Versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis

The journal of clinical endocrinology and metabolism, 1997-02, Vol.82 (2), p.620-628

1997

Volltextzugriff (PDF)

Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma

Journal of allergy and clinical immunology, 1995-08, Vol.96 (2), p.157-166

1995

Volltextzugriff (PDF)

Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation

Bone (New York, N.Y.), 2000-03, Vol.26 (3), p.221-225

2000

Volltextzugriff (PDF)

Management of corticosteroid-induced osteoporosis

Seminars in arthritis and rheumatism, 2000-02, Vol.29 (4), p.228-251

2000

Volltextzugriff (PDF)

An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis

The Journal of clinical investigation, 1993-03, Vol.91 (3), p.1138-1148

1993

Volltextzugriff (PDF)

Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats

Bone (New York, N.Y.), 1995-03, Vol.16 (3), p.357-365

1995

Volltextzugriff (PDF)

Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: Evidence for de novo bone formation on quiescent cancellous surfaces

Bone (New York, N.Y.), 1993, Vol.14 (3), p.523-527

1993

Volltextzugriff (PDF)

Use of FTIR Spectroscopic Imaging to Identify Parameters Associated With Fragility Fracture

Journal of bone and mineral research, 2009-09, Vol.24 (9), p.1565-1571

2009

Volltextzugriff (PDF)

Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate

The journal of clinical endocrinology and metabolism, 2008-10, Vol.93 (10), p.3785-3793

2008

Volltextzugriff (PDF)

Comparison of the biochemical responses to human parathyroid Hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans

The journal of clinical endocrinology and metabolism, 1999-08, Vol.84 (8), p.2739-2743

1999

Volltextzugriff (PDF)

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

Osteoporosis international, 2012, Vol.23 (1), p.351-363

2012

Volltextzugriff (PDF)

The impact of physician characteristics on bone mineral density ordering: Canadian Quality Circle (CQC) national project

Bone (New York, N.Y.), 2009-06, Vol.44, p.S377-S377

2009

Volltextzugriff (PDF)

1 – 25 von 371

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(303)
Mit Volltextzugriff
(300)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(370)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Online Fundraisers: Targeted Planning and Successful Implementation

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

Risk factors for low bone mass in healthy 40-60 year old women: A systematic review of the literature

Trabecular bone score in kidney transplant recipients

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Rates and Properties of Type Ia Supernovae as a Function of Mass and Star Formation in Their Host Galaxies

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis

Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

Long‐term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial

Nuclear Localization of the Type 1 PTH/PTHrP Receptor in Rat Tissues

Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone Versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis

Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma

Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation

Management of corticosteroid-induced osteoporosis

An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis

Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats

Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: Evidence for de novo bone formation on quiescent cancellous surfaces

Use of FTIR Spectroscopic Imaging to Identify Parameters Associated With Fragility Fracture

Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate

Comparison of the biochemical responses to human parathyroid Hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

The impact of physician characteristics on bone mineral density ordering: Canadian Quality Circle (CQC) national project

Suchergebnisse filtern